https://www.fiercebiotech.com/biotech/roche-tasks-avista-scaavenging-better-eye-disease-gene-therapy-vectors
Roche tasks Avista with scAAVenging better gene therapy vectors
Jul 19, 2022 - In a heavily backloaded deal, Roche has offered up $1 billion to secure the right to assess and license AAV capsids developed by Avista.
gene therapyrochetasksavistabetter